Hetlioz is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Vanda Pharmaceuticals Inc.. The primary component is Tasimelteon.
| Product ID | 43068-220_046bf85f-3017-415f-a709-4d849c8d2744 |
| NDC | 43068-220 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Hetlioz |
| Generic Name | Tasimelteon |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-04-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205677 |
| Labeler Name | Vanda Pharmaceuticals Inc. |
| Substance Name | TASIMELTEON |
| Active Ingredient Strength | 20 mg/1 |
| Pharm Classes | Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2014-04-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205677 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-04-04 |
| Ingredient | Strength |
|---|---|
| TASIMELTEON | 20 mg/1 |
| SPL SET ID: | ca4a9b63-708e-49e9-8f9b-010625443b90 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43068-220 | Hetlioz | tasimelteon |
| 43068-304 | Hetlioz | tasimelteon |
| 0480-4490 | Tasimelteon | Tasimelteon |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HETLIOZ 97791877 not registered Live/Pending |
Vanda Pharmaceuticals Inc. 2023-02-13 |
![]() HETLIOZ 88981892 not registered Live/Pending |
Vanda Pharmaceuticals Inc. 2019-04-01 |
![]() HETLIOZ 88366716 not registered Live/Pending |
Vanda Pharmaceuticals Inc. 2019-04-01 |
![]() HETLIOZ 85383242 4552099 Live/Registered |
Vanda Pharmaceuticals Inc. 2011-07-28 |